Thomas Tüting

14PUBLICATIONS
86CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitors.

Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs

|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade.

Miriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs

|Feb 15, 2024
Transactivation of Met signaling by oncogenic Gnaq drives the evolution of melanoma in Hgf-Cdk4 mice.

Miriam Mengoni, Andreas Dominik Braun, Sahithi Seedarala

|Jan 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activation.

Meri Rogava, Tyler J Aprati, Wei-Yu Chi

|Jun 14, 2023
CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours.

Bastian Kruse, Anthony C Buzzai, Naveen Shridhar

|Aug 12, 2022
Neutrophils activated by membrane attack complexes increase the permeability of melanoma blood vessels.

Xiaobo Liu, Yuanyuan Wang, Alexander T Bauer

Pageof 3

Frequent Collaborators

5 joint publications

Andreas Dominik Braun

4 joint publications

Miriam Mengoni

4 joint publications

Evelyn Gaffal

2 joint publications

Hamid Kashkar